We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+16.6%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$328M
AUM Growth
+$45.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$140M 42.62%
8,643,739
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$120M 36.54%
3,440,419
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
$58.8M 17.96%
4,763,602
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.4M 2.56%
90,215
BGMS
5
Bio Green Med Solution Inc
BGMS
$5.05M
$1.02M 0.31%
8

Similar funds

Tang Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Tang Capital Management held 5 positions worth $328M, up 16% from $282M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 0%. Tang Capital Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tang Capital Management's ten largest holdings make up 100% of its $328M portfolio in Q3 2017.
  • Tang Capital Management opened 0 new positions and closed 0 in Q3 2017.
  • Tang Capital Management's portfolio value rose 16% quarter-over-quarter to $328M.

Based on Tang Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.